AIROLDI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 17.305
EU - Europa 10.196
AS - Asia 8.418
SA - Sud America 1.208
AF - Africa 139
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 8
Totale 37.303
Nazione #
US - Stati Uniti d'America 16.827
IT - Italia 2.829
SG - Singapore 2.655
CN - Cina 2.026
DE - Germania 1.930
VN - Vietnam 1.617
RU - Federazione Russa 1.018
HK - Hong Kong 990
BR - Brasile 971
SE - Svezia 868
IE - Irlanda 563
PL - Polonia 542
GB - Regno Unito 486
UA - Ucraina 411
DK - Danimarca 365
CA - Canada 354
FR - Francia 342
IN - India 273
FI - Finlandia 220
AT - Austria 162
ID - Indonesia 129
TR - Turchia 120
KR - Corea 116
NL - Olanda 110
AR - Argentina 93
JP - Giappone 92
ES - Italia 91
MX - Messico 82
BD - Bangladesh 80
ZA - Sudafrica 58
BE - Belgio 46
PK - Pakistan 46
IQ - Iraq 44
EC - Ecuador 35
RO - Romania 35
CH - Svizzera 33
UZ - Uzbekistan 31
LT - Lituania 29
PT - Portogallo 27
CL - Cile 25
CZ - Repubblica Ceca 25
CO - Colombia 24
IR - Iran 23
TW - Taiwan 23
PE - Perù 21
PH - Filippine 21
AU - Australia 20
SA - Arabia Saudita 20
EG - Egitto 19
JO - Giordania 17
MA - Marocco 15
VE - Venezuela 15
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
GR - Grecia 11
MY - Malesia 11
PY - Paraguay 10
TN - Tunisia 10
AZ - Azerbaigian 9
CR - Costa Rica 9
KE - Kenya 9
BY - Bielorussia 8
EU - Europa 8
HU - Ungheria 8
IL - Israele 8
NZ - Nuova Zelanda 8
UY - Uruguay 8
ET - Etiopia 7
NP - Nepal 7
SV - El Salvador 7
DO - Repubblica Dominicana 6
SY - Repubblica araba siriana 6
GE - Georgia 5
LB - Libano 5
RS - Serbia 5
TH - Thailandia 5
AL - Albania 4
AM - Armenia 4
BG - Bulgaria 4
BO - Bolivia 4
HN - Honduras 4
LV - Lettonia 4
PA - Panama 4
SN - Senegal 4
BH - Bahrain 3
CY - Cipro 3
EE - Estonia 3
GT - Guatemala 3
KH - Cambogia 3
LU - Lussemburgo 3
NI - Nicaragua 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PS - Palestinian Territory 2
Totale 37.278
Città #
Ann Arbor 4.738
Singapore 1.573
Ashburn 1.382
Frankfurt am Main 1.202
Milan 1.124
Woodbridge 1.000
Hong Kong 962
Wilmington 923
Fairfield 846
Chandler 763
Houston 589
Dublin 541
Kraków 476
Dallas 438
Ho Chi Minh City 422
Jacksonville 398
New York 379
Seattle 376
Beijing 375
Hanoi 370
Santa Clara 325
San Jose 295
Dearborn 289
Cambridge 280
Los Angeles 280
Hefei 212
Princeton 196
Dong Ket 170
Guangzhou 134
Vienna 131
Nanjing 129
The Dalles 128
Shanghai 118
São Paulo 104
Buffalo 98
Helsinki 98
Toronto 98
Seoul 95
Chicago 90
Jakarta 90
Lawrence 87
Moscow 80
Altamura 78
Rome 77
Munich 70
Boardman 68
Hangzhou 67
Montréal 64
Lachine 63
Kent 56
San Diego 53
Council Bluffs 52
Brooklyn 50
Chennai 50
London 50
Orem 48
Tokyo 48
Nuremberg 47
Denver 45
Warsaw 44
Nanchang 43
Brussels 42
Da Nang 42
Ottawa 42
Tianjin 42
Desio 40
Stockholm 40
Fremont 38
Poplar 37
Andover 36
Changsha 36
Grafing 36
Ha Long 34
Haiphong 34
Montreal 34
Phoenix 34
Shenyang 34
Turku 34
Manchester 33
Boston 32
Brescia 32
Atlanta 31
Biên Hòa 31
Florence 29
Tashkent 29
Hebei 28
Jinan 28
Mexico City 28
Ankara 27
Cinisello Balsamo 27
Hải Dương 27
Johannesburg 27
Quận Bình Thạnh 27
Dhaka 26
Hyderabad 26
Amsterdam 24
Ninh Bình 24
Parma 24
Pune 24
Belo Horizonte 22
Totale 24.718
Nome #
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 742
Coffee variety, origin and extraction procedure: Implications for coffee beneficial effects on human health 704
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 695
Green coffee extract enhances oxidative stress resistance and delays aging in Caenorhabditis elegans 630
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 604
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 602
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 596
Natural compounds in cancer prevention: effects of coffee extracts and their main polyphenolic component 5-CQA on oncogenic Ras proteins 562
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 557
Methacycline displays a strong efficacy in reducing toxicity in a SCA3 Caenorhabditis elegans model 552
Xanthohumol destabilizes the structure of amyloid-β (Aβ) oligomers and promotes the formation of high-molecular-weight amorphous aggregates 547
Sugar-derived Ras inhibitors: Group epitope mapping by NMR spectroscopy and biological evaluation 496
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 493
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 478
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 474
Re LPS biogenetic pathway: Enzyme characterisation and synthetic efforts towards inhibitors 473
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 470
Glycoconjugates in cancer therapy 465
Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural cells and Caenorhabditis elegans animal model 462
Glycan carriers as glycotools for medicinal chemistry applications 462
Studies on the mechanism of action of a new class of inhibitors of Ras activation 442
Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide 425
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 419
Nuclear Magnetic Resonance as an Attractive Resource for Monitoring Surveillance Candidates of Acute and Chronic Lung Disorders 417
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 413
Flavonoids in the treatment of alzheimer’s and other neurodegenerative diseases 404
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages 382
bioNMR-based identification of natural anti-Aβ compounds in Peucedanum ostruthium 378
From cancer metabolism to new biomarkers and drug targets 361
Phosphonate Analogues of Arabinose 5-Phosphate: Putative Ligands for Arabinose 5-Phosphate Isomerases 349
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 347
Effectiveness of Vigna unguiculata seed extracts in preventing colorectal cancer 346
On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor 342
Methionine supplementation stimulates mitochondrial respiration 338
Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors 337
Flavonoids and their glycosides as anti-amyloidogenic compounds: Aβ1-42 interaction studies to gain new insights on their potential for Alzheimer's disease prevention and therapy 335
New targets for antibacterial design: Kdo biosynthesis and LPS machinery transport to the cell surface 333
Versatile and efficient targeting using a single nanoparticulate platform: Application to cancer and alzheimer's disease 332
Natural glycoconjugates with antitumor activity 331
Enhanced amino acid utilization sustains growth of cells lacking Snf1/AMPK 328
How Epigallocatechin-3-gallate and Tetracycline Interact with the Josephin Domain of Ataxin-3 and Alter Its Aggregation Mode 328
Metabolomic profiling of beers: Combining 1H NMR spectroscopy and chemometric approaches to discriminate craft and industrial products 326
1H NMR to Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification 321
Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid b1-42 peptide 318
Structural modifications of cis-glycofused benzopyran compounds and their influence on the binding to amyloid-β peptide 314
NMR analysis of budding yeast metabolomics: A rapid method for sample preparation 310
Targeting bacterial biofilm: a new LecA multivalent ligand with inhibitory activity 310
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 306
Cis-Glyco-Fused Benzopyran Derivatives as Hit Compounds for the Development of Therapeutic and Diagnostic Tools against Neurodegenerative Diseases 305
Curcumin derivatives as new ligands of Aβ peptides 304
Towards a universal approach based on omics technologies for the quality control of food 303
The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and developmen 300
Carbohydrate Mimetics and Scaffolds: Sweet Spots in Medicinal Chemistry 299
Cell-Free and In Vivo Characterization of the Inhibitory Activity of Lavado Cocoa Flavanols on the Amyloid Protein Ataxin-3: Toward New Approaches against Spinocerebellar Ataxia Type 3 293
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 293
Targeting bacterial membranes: NMR spectroscopy characterization of substrate recognition and binding requirements of D-arabinose-5-phosphate isomerase 291
Carbohyrate scaffolds in chemical genetic studies 291
Antimicrobial peptides: Insights into membrane permeabilization, lipopolysaccharide fragmentation and application in plant disease control 289
Synthesis and biological evaluation of arabinose 5-phosphate mimics modified at position five 284
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 284
Synthesis and biological evaluation of a small library of nojirimycin derived bicyclic iminosugars 279
The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins 272
NMR Molecular Recognition Studies for the Elucidation of Protein and Nucleic Acid Structure and Function 272
1H NMR to Explore the Metabolome of Exhaled Breath Condensate in α1-Antitrypsin Deficient Patients: A Pilot Study 271
Targeting Bacterial Membranes: Identification of Pseudomonas aeruginosaD-Arabinose-5P Isomerase and NMR Characterisation of its Substrate Recognition and Binding Properties 268
Multivalent calix[4]arene-based mannosylated dendrons as new FimH ligands and inhibitors 267
Curcumin derivatives: Aβ-ligands as potential diagnostic and therapeutic tools for alzheimer's disease 267
Cheese-whey permeate improves the fitness of Escherichia coli cells during recombinant protein production 262
Fructose-based proline analogues: Exploring the prolyl trans/cis-amide rotamer population in model peptides 261
Fluorinated Arabinose-5-Phosphate Analogues as Potential Antibactericals 258
On-cell NMR screening of multivalent ligands for bacterial targeting 255
Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs 252
Solid-phase supported mimic of GDP-l-galactose 251
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 249
Tetracycline prevents Aβ oligomer toxicity through an atipical supramolecular interaction 247
On-cell Saturation Transfer Difference NMR for the identification of FimH ligands and inhibitors 246
NMR Protein-Ligand Interaction Studies under Non-Homogeneous Conditions for Biomaterial Generation: A Model For Artificial Lectin-Carbohydrate Recognition 243
Cis-glyco-fused benzopyran compounds as new amyloid β peptide ligands 242
Fluorescent amyloid β-peptide ligand derivatives as potential diagnostic tools for Alzheimer's disease 240
Exploiting the Therapeutic Potential of 8-β-d-Glucopyranosylgenistein: Synthesis, Antidiabetic Activity, and Molecular Interaction with Islet Amyloid Polypeptide and Amyloid β-Peptide (1-42) 233
Nutraceutical approach to increase healthy aging using Caenorhabditis elegans as a model organism 231
Natural Compounds against Neurodegenerative Diseases: Molecular Characterization of the Interaction of Catechins from Green Tea with Aβ1-42, PrP106-126, and Ataxin-3 Oligomers 229
Development of new potential antitumor drugs based on Ras protein inhibition 226
Synthesis of 3-Deoxy-D-threopentofuranose 5-Phosphate, a Substrate of Arabinose 5-Phosphate Isomerase 217
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 216
Sugar-Based Enantiomeric and Conformationally Constrained Pyrrolo[2,1-c][1,4]-Benzodiazepines as Potential GABAALigands 215
Antarctic Soil Metabolomics: A Pilot Study 212
Clustering Zwitterionic Amino Acids at the Upper Rim of Cone Calix[4]arene Triggers the Selective Recognition of Gram-Negative Bacterial Envelope 211
A Contribution to the Harmonization of Non-targeted NMR Methods for Data-Driven Food Authenticity Assessment 211
Aβ Monomers, Oligomers and Fibrils: Structural Features 208
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 206
New C-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. Therapeutic applications of the synthesized agent(s) and of Genista tenera ethyl acetate extracts containing some of those agents 204
Saturation Transfer Difference NMR Experiments of Membrane Proteins in Living Cells under HR-MAS Conditions: the Interaction of the SGLT1 Co-transporter with Its Ligands 200
Mechanistic and Structural Insights on Difluoromethyl-1,3,4-Oxadiazole Inhibitors of HDAC6 199
Synthesis of C- and S-Glycosides 199
Natural Compounds against Alzheimer´s Disease: Molecular Recognition of Aβ1–42 Peptide by Salvia sclareoides Extract and its Major Component, Rosmarinic Acid, as Investigated by NMR 196
Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models 196
Global Scientific Challenges: Perspectives from Young Scientists 195
Adjuvant Effect of Cinnamon Polyphenolic Components in Colorectal Cancer Cell Lines 193
New tricyclic compounds, process for their manufacture and their use as ligands of beta-alyloid peptides 193
Totale 33.784
Categoria #
all - tutte 108.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.087


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.508 0 0 0 0 0 0 362 404 375 494 294 579
2021/20223.283 308 342 310 309 161 271 222 154 283 246 273 404
2022/20233.885 498 944 488 370 326 514 127 195 199 57 99 68
2023/20242.424 104 119 158 188 269 483 376 131 181 68 99 248
2024/20255.977 282 582 519 308 425 274 279 230 594 881 543 1.060
2025/20269.371 2.067 1.116 1.270 1.720 1.707 722 769 0 0 0 0 0
Totale 38.384